Display options
Cite
Kiiski K, Lehtokari VL, Manzur AY, et al. A Large Deletion Affecting TPM3, Causing Severe Nemaline Myopathy. J Neuromuscul Dis. 2015;2(4):433-438doi: 10.3233/JND-150107.
Kiiski, K., Lehtokari, V. L., Manzur, A. Y., Sewry, C., Zaharieva, I., Muntoni, F., Pelin, K., & Wallgren-Pettersson, C. (2015). A Large Deletion Affecting TPM3, Causing Severe Nemaline Myopathy. Journal of neuromuscular diseases, 2(4), 433-438. https://doi.org/10.3233/JND-150107
Kiiski, K, et al. "A Large Deletion Affecting TPM3, Causing Severe Nemaline Myopathy." Journal of neuromuscular diseases vol. 2,4 (2015): 433-438. doi: https://doi.org/10.3233/JND-150107
Kiiski K, Lehtokari VL, Manzur AY, Sewry C, Zaharieva I, Muntoni F, Pelin K, Wallgren-Pettersson C. A Large Deletion Affecting TPM3, Causing Severe Nemaline Myopathy. J Neuromuscul Dis. 2015 Sep 21;2(4):433-438. doi: 10.3233/JND-150107. PMID: 27858751; PMCID: PMC5240603.
Copy Download .nbib Format: NLM
Share it on

J Neuromuscul Dis. 2015 Sep 21;2(4):433-438. doi: 10.3233/JND-150107.

A Large Deletion Affecting TPM3, Causing Severe Nemaline Myopathy.

Journal of neuromuscular diseases

K Kiiski, V-L Lehtokari, A Y Manzur, C Sewry, I Zaharieva, F Muntoni, K Pelin, C Wallgren-Pettersson

Affiliations

  1. The Folkhälsan Institute of Genetics and the Department of Medical and Clinical Genetics, Medicum, University of Helsinki, Helsinki, Finland.
  2. Great Ormond Street Hospital, London, UK.
  3. Dubowitz Neuromuscular Centre, UCL Institute of Child Health, London, UK.
  4. Department of Biosciences, Division of Genetics, University of Helsinki, Helsinki, Finland.

PMID: 27858751 PMCID: PMC5240603 DOI: 10.3233/JND-150107

Abstract

BACKGROUND AND OBJECTIVES: Nemaline myopathy may be caused by pathogenic variants in the TPM3 gene and is then called NEM1. All previously identified disease-causing variants are point mutations including missense, nonsense and splice-site variants. The aim of the study was to identify the disease-causing gene in this patient and verify the NM diagnosis.

METHODS: Mutation analysis methods include our self-designed nemaline myopathy array, The Nemaline Myopathy Comparative Genomic Hybridisation Array (NM-CGH array), whole-genome array-CGH, dHPLC, Sanger sequencing and whole-exome sequencing. The diagnostic muscle biopsy was investigated further by routine histopathological methods.

RESULTS: We present here the first large (17-21 kb) aberration in the α-tropomyosinslow gene (TPM3), identified using the NM-CGH array. This homozygous deletion removes the exons 1a and 2b as well as the promoter of the TPM3 isoform encoding Tpm3.12st. The severe phenotype included paucity of movement, proximal and axial weakness and feeding difficulties requiring nasogastric tube feeding. The infant died at the age of 17.5 months. Muscle biopsy showed variation in fibre size and rods in a population of hypotrophic muscle fibres expressing slow myosin, often with internal nuclei, and abnormal immunolabelling revealing many hybrid fibres.

CONCLUSIONS: This is the only copy number variation we have identified in any NM gene other than nebulin (NEB), suggesting that large deletions or duplications in these genes are very rare, yet possible, causes of NM.

Keywords: DNA copy number variation; NM-CGH array; Nemaline myopathy; TPM3; alpha-tropomyosin; array comparative genomic hybridization; deletion mutation; exome sequencing; rod myopathy

References

  1. Neuromuscul Disord. 2014 Apr;24(4):331-4 - PubMed
  2. Eur J Hum Genet. 2008 Sep;16(9):1055-61 - PubMed
  3. Neurology. 2002 Aug 27;59(4):613-7 - PubMed
  4. J Neuropathol Exp Neurol. 2003 Oct;62(10):977-89 - PubMed
  5. Hum Mutat. 2014 Dec;35(12):1418-26 - PubMed
  6. Bioarchitecture. 2011 Jan;1(1):49-59 - PubMed
  7. J Immunol. 2014 Aug 1;193(3):1301-13 - PubMed
  8. Hum Mutat. 2010 Feb;31(2):176-83 - PubMed
  9. Hum Mutat. 2014 Jul;35(7):779-90 - PubMed
  10. J Muscle Res Cell Motil. 2015 Apr;36(2):147-53 - PubMed
  11. Neuromuscul Disord. 2009 Oct;19(10):685-8 - PubMed
  12. Neuromuscul Disord. 2013 Jan;23(1):56-65 - PubMed
  13. Ann Neurol. 2008 Mar;63(3):329-37 - PubMed
  14. Dev Biol. 1990 Apr;138(2):443-53 - PubMed
  15. Neurology. 1969 Jun;19(6):591-605 - PubMed
  16. Trends Cell Biol. 2005 Jun;15(6):333-41 - PubMed
  17. Nat Genet. 1995 Jan;9(1):75-9 - PubMed
  18. Mol Cell Biol. 2004 Mar;24(6):2318-23 - PubMed
  19. Neuromuscul Disord. 1999 Dec;9(8):573-9 - PubMed

Publication Types